Disparities in Biomarkers for Patients With Diabetes After the Affordable Care Act
Background: Racial and ethnic minorities are disproportionately affected by diabetes and at greater risk of experiencing poor diabetesrelated outcomes compared with non-Hispanic whites. The Affordable Care Act (ACA) was implemented to increase health insurance coverage and reduce health disparities. Objective: Assess changes in diabetes-associated biomarkers [hemoglobin A1c (HbA1c) and low-density lipoprotein] 24 months pre-ACA to 24 months post-ACA Medicaid expansion by race/ethnicity and insurance group. Research Design: Retrospective cohort study of community health center (CHC) patients. Subjects: Patients aged 19–64 with diabetes living in 1 of 10 Medicaid expansion states with ≥1 CHC visit and ≥1 HbA1c measurement in both the pre-ACA and the post-ACA time periods (N=13,342)
Locate the Document
Marino, M., Angier, H., Fankhauser, K., Valenzuela, S., Hoopes, M., Heintzman, J., ... & Huguet, N. (2020). Disparities in Biomarkers for Patients With Diabetes After the Affordable Care Act. Medical Care, 58, S31-S39.